Skip to main content
Livermore
Livermore
ZHEN

Macquarie Group Ltd

SEC CIK
0001418333
Latest filing
Aug 14, 2026

NBIX holding history

Neurocrine Biosciences Inc in every 13F filed by Macquarie Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NBIX overviewAll 13F holders of NBIXFull Q2 2026 holdings

Shares (Q2 2026)
13,870
Value
$2.34M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NBIX by Macquarie Group Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202613,870$2.34M<0.1%+2,044+17.3%AddedHolders
Q1 202611,826$1.56M<0.1%+806+7.3%AddedHolders
Q4 202511,020$1.56M<0.1%−304,442−96.5%ReducedHolders
Q3 2025315,462$44.3M0.1%+44,960+16.6%AddedHolders
Q2 2025270,502$34.0M<0.1%+39,154+16.9%AddedHolders
Q1 2025231,348$25.6M<0.1%−42,778−15.6%ReducedHolders
Q4 2024274,126$37.4M<0.1%−218,064−44.3%ReducedHolders
Q3 2024492,190$56.7M0.1%+221,213+81.6%AddedHolders
Q2 2024270,977$37.3M<0.1%−5,033−1.8%ReducedHolders
Q1 2024276,010$38.1M<0.1%−52,119−15.9%ReducedHolders
Q4 2023328,129$43.2M<0.1%+69,518+26.9%AddedHolders
Q3 2023258,611$29.1M<0.1%−816−0.3%ReducedHolders
Q2 2023259,427$24.5M<0.1%−33,183−11.3%ReducedHolders
Q1 2023292,610$29.6M<0.1%+7,296+2.6%AddedHolders
Q4 2022285,314$34.1M<0.1%−990−0.3%ReducedHolders
Q3 2022286,304$30.4M<0.1%−6,586−2.2%ReducedHolders
Q2 2022292,890$28.6M<0.1%−25,173−7.9%ReducedHolders
Q1 2022318,063$29.8M<0.1%+65,302+25.8%AddedHolders
Q4 2021252,761$21.5M<0.1%+18,676+8.0%AddedHolders
Q3 2021234,085$22.5M<0.1%−2,371−1.0%ReducedHolders
Q2 2021236,456$23.0M<0.1%+7,699+3.4%AddedHolders
Q1 2021228,757$22.2M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.